Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells

British Journal of Pharmacology

Volumn 132, Issue 7, 2001, Pages 1441-1446

  Bretschneider, E ^a   Kaufmann, R ^a   Braun, M ^b   Nowak, G ^a   Glusa, E ^a   Schror K ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

ERK 1 2; Mitogenesis; PAR 4; Vascular smooth muscle cells

Indexed keywords

CALCIUM; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR PROTEIN; SYNTHETIC PEPTIDE; THROMBIN; THYMIDINE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME KINETICS; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0035066614     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703947     Document Type: Article

References (28)

1. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{([4-(1-methylethyl)phenyl]-methyl} -7H-pyrrolo[3,2-f]quinazoline-l,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist
2. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor
3. Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts
4. Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells
5. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intramolecular liganding mode
6. Protease-activated receptors and platelet function
7. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function
8. 2+ indicators with greatly improved fluorescence properties
9. Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor. Effect of heparin
10. Proteinase-activated receptor 4 (PAR4): Action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2
11. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase
12. Protease-activated receptor 3 is a second thrombin receptor in humans
13. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
14. Involvement of pertussis toxin-sensitive and -insensitive G proteins in α-thrombin signalling on cultered human vascular smooth muscle cells
15. Thrombin-induced proliferation and expression of platelet-derived growth factor-A chain gene in human vascular smooth muscle cells
16. i mobilization in human astrocytoma cells
17. Modulation of airway smooth muscle tone by protease activated receptor-1, -2, -3 and -4 in trachea isolated from influenza A virus-infected mice
18. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
19. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
20. Molecular cloning of a potential proteinase activated receptor
21. Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting
22. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin
23. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
24. Domains specifying thrombin-receptor interaction
25. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors
26. Cloning and characterisation of human protease-activated receptor 4
27. Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure
28. 1 in coronary artery smooth muscle cells